162 related articles for article (PubMed ID: 23852840)
21. Microencapsulated Pomegranate Reverts High-Density Lipoprotein (HDL)-Induced Endothelial Dysfunction and Reduces Postprandial Triglyceridemia in Women with Acute Coronary Syndrome.
Estrada-Luna D; Carreón-Torres E; Bautista-Pérez R; Betanzos-Cabrera G; Dorantes-Morales A; Luna-Luna M; Vargas-Barrón J; Mejía AM; Fragoso JM; Carvajal-Aguilera K; García-Trejo JJ; Vargas-Alarcón G; Pérez-Méndez Ó
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349559
[TBL] [Abstract][Full Text] [Related]
22. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
23. Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
Roe MT; Ou FS; Alexander KP; Newby LK; Foody JM; Gibler WB; Boden WE; Ohman EM; Smith SC; Peterson ED
Eur Heart J; 2008 Oct; 29(20):2480-8. PubMed ID: 18716006
[TBL] [Abstract][Full Text] [Related]
24. Paraoxonase 1 and HDL maturation.
Gugliucci A; Menini T
Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of dysfunctional high-density lipoprotein levels with myeloperoxidase/paraoxonase-1 ratio in rheumatoid arthritis.
Alisik T; Alisik M; Nacir B; Ayhan FF; Genc H; Erel O
Int J Clin Pract; 2021 Jul; 75(7):e14172. PubMed ID: 33756027
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
27. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
Hafiane A; Jabor B; Ruel I; Ling J; Genest J
Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
[TBL] [Abstract][Full Text] [Related]
28. Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1.
Bacchetti T; Ferretti G; Carbone F; Ministrini S; Montecucco F; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2021; 28(14):2842-2850. PubMed ID: 32674726
[TBL] [Abstract][Full Text] [Related]
29. The association of serum neutrophil markers and acute coronary syndrome.
Alfakry H; Sinisalo J; Paju S; Nieminen MS; Valtonen V; Tervahartiala T; Pussinen PJ; Sorsa T
Scand J Immunol; 2012 Aug; 76(2):181-7. PubMed ID: 22537345
[TBL] [Abstract][Full Text] [Related]
30. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
31. Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Zsíros N; Koncsos P; Lőrincz H; Seres I; Katkó M; Szentpéteri A; Varga VE; Fülöp P; Paragh G; Harangi M
Clin Biochem; 2016 Aug; 49(12):862-7. PubMed ID: 27129797
[TBL] [Abstract][Full Text] [Related]
32. High-density lipoprotein dysfunction in carotid artery stenosis.
Senat A; Ilker Yon M; Yuce G; Deniz O; Erel O
Vasa; 2023 Sep; 52(5):342-348. PubMed ID: 37622201
[No Abstract] [Full Text] [Related]
33. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
34. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M
J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
36. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
[TBL] [Abstract][Full Text] [Related]
37. Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome.
Taylor JK; Plaisance EP; Mahurin AJ; Mestek ML; Moncada-Jimenez J; Grandjean PW
Redox Rep; 2015 Jan; 20(1):42-8. PubMed ID: 25180827
[TBL] [Abstract][Full Text] [Related]
38. Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Sentürk T; Sarandöl E; Güllülü S; Erdinç S; Ozdemir B; Baran I; Aydinlar A
Acta Cardiol; 2008 Jun; 63(3):361-7. PubMed ID: 18664028
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
[TBL] [Abstract][Full Text] [Related]
40. Dysfunctional HDL in acute stroke.
Ortiz-Munoz G; Couret D; Lapergue B; Bruckert E; Meseguer E; Amarenco P; Meilhac O
Atherosclerosis; 2016 Oct; 253():75-80. PubMed ID: 27591364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
